Elute
1 known investors
Find your way into Elute
Elut is a clinical-stage medical device company developing patented drug-eluting devices that provide controlled, sustained therapeutic release, with a current focus on treating orthopedic and periprosthetic joint infections. Its technology is applied to bone void fillers that deliver local antibiotics over an eight-week period.
Investors · 1
Frequently asked questions
- What does Elute do?
- Elut is a clinical-stage medical device company developing patented drug-eluting devices that provide controlled, sustained therapeutic release, with a current focus on treating orthopedic and periprosthetic joint infections. Its technology is applied to bone void fillers that deliver local antibiotics over an eight-week period.
- Who are Elute's investors?
- Elute's investors include UpStart Ventures.